OncoC4

Pharmaceutical Manufacturing • 9640 Medical Center Dr, Rockville, United States • 51-100 Employees

Company overview

Headquarters	9640 Medical Center Dr, Rockville, Maryland 20850, US
Website	oncoc4.com
NAICS	3254
Founded	2020
Employees	51-100
Socials

Key Contacts at OncoC4

Rick Ohara

Director, R&D Business Operations

Pan Pan

Senior Director, Head Of Business Development

Ido Weiss

Senior Director Of Translational Research

Qiang Yang

Director Of Protein Engineering

Rosetta Cavallo

Associate Director Clinical Operations

Fang Liu

Executive Director, Oncoc4 Australian Branch

Katherine Blackburn

Associate Director, Clinical Project Management

Chris Po Leung

Director, Clinical Science

Wei Wu

Director Of Operations

Deren Huang

Medical Director

OncoC4 Email Formats

OncoC4 uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@oncoc4.com), used 59.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@oncoc4.com	59.7%
{first name}{last name}	johndoe@oncoc4.com	25.8%
{last name}{last name}	doedoe@oncoc4.com	8.1%
{first initial}{second initial}{last name}	jodoe@oncoc4.com	1.6%
{first name}.{last name}	john.doe@oncoc4.com	1.6%

About OncoC4

Based in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologics for the potential treatment of cancer. Its lead clinical candidate is BNT316/ONC-392, a next generation anti-CTLA-4 antibody that is designed to allow CTLA-4 to recycle and maintain its protective function against autoimmune diseases while enhancing anti-tumor activity at the same time. In addition, OncoC4 has a pipeline of potentially first-in-class preclinical product candidates focusing on the CD24-Siglecs cancer immune evasion pathway.

OncoC4 revenue & valuation

Annual revenue	$5,646,630
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$18,100,000
Total funding	$50,000,000